SCHEMBL6568801

SCHEMBL6568801

C=C(CC(=O)c1ccccc1)NC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.61
▸ HPGD P15428 4/20 0.61
▸ MAPT P10636 4/20 0.61
▸ MEN1 O00255 3/20 0.61
▸ MAPK1 P28482 3/20 0.61
▸ CYP3A4 P08684 3/20 0.61
▸ SMN1; SMN2 Q16637 2/20 0.61
▸ TDP1 Q9NUW8 2/20 0.61
▸ KDM4E B2RXH2 1/20 0.61
▸ ALOX15 P16050 1/20 0.61
▸ CES1 P23141 1/20 0.61
▸ NPC1 O15118 2/20 0.55
▸ RAB9A P51151 2/20 0.55
▸ PTPN1 P18031 2/20 0.53
▸ ERCC5 P28715 1/20 0.53
▸ FEN1 P39748 1/20 0.53
▸ ALDH1A1 P00352 5/20 0.50
▸ HIF1A Q16665 2/20 0.50
▸ PLOD2 O00469 2/20 0.50
▸ CYP1A2 P05177 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL487605 0.79 KMT2A (0.67) KMT2AHPGDMAPTMEN1MAPK1
SCHEMBL1200149 0.79 KMT2A (0.67) KMT2AHPGDMAPTMEN1MAPK1
Dibenzoylmethane SCHEMBL39582 0.78 MEN1 (1.00) KMT2AHPGDMAPTMEN1MAPK1
Dibenzoylmethane SCHEMBL1704711 0.78 MEN1 (1.00) KMT2AHPGDMAPTMEN1MAPK1
Dibenzoylmethane SCHEMBL10356288 0.78 MEN1 (1.00) KMT2AHPGDMAPTMEN1MAPK1
SCHEMBL547080 0.77 MAPT (0.70) KMT2AHPGDMAPTMEN1MAPK1
SCHEMBL14417637 0.76 ERCC5 (0.64) KMT2AHPGDMAPTMEN1MAPK1
SCHEMBL5931323 0.76 KMT2A (0.61) KMT2AHPGDMAPTMEN1MAPK1
Dibenzoylmethane SCHEMBL11587518 0.75 MEN1 (0.94) KMT2AHPGDMAPTMEN1MAPK1
Dibenzoylmethane SCHEMBL4205247 0.75 MEN1 (0.94) KMT2AHPGDMAPTMEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040105875-A1 Composition containing a secondary or tertiary carbonyl amine, method of use thereof, compounds L'OREAL (FR) 2004-06-03 — — US disclosed
EP-1405633-A1 Composition, particularly for cosmetics containing an aromatic aminoketone L'OREAL (FR) 2004-04-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040105875-A1 Composition containing a secondary or tertiary carbonyl amine, method of use thereof, compounds CUTA, COL1A1, COL14A1 KMT2A 1218/4885HPGD 476/4885MAPT 1352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback